Safety of Teropavimab and Zinlirvimab with Lenacapavir Once Every 6 Months for HIV Treatment: a Phase 1b, Randomised, Proof-of-concept Study.
LANCET HIV(2024)
Key words
Antiretroviral Therapy,HIV
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined